Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CrossAmerica Partners LP Unit | CAPL | Jul 29, 2024 | 20.16 | +0.15 |
CrossFirst Bankshares | CFB | Jul 29, 2024 | 18.65 | -0.16 |
CrowdStrike A | CRWD | Jul 29, 2024 | 258.81 | +1.03 |
Crown Castle | CCI | Jul 29, 2024 | 108.13 | +0.57 |
Crown Crafts | CRWS | Jul 29, 2024 | 4.99 | -0.20 |
Crown ElectroKinetics | CRKN | Jul 29, 2024 | 3.09 | +3.34 |
Crown Holdings | CCK | Jul 29, 2024 | 86.78 | +1.28 |
Crown LNG | CGBS | Jul 29, 2024 | 0.73 | 0.00 |
Cryo-Cell International | CCEL | Jul 29, 2024 | 7.92 | +6.31 |
CryoPort | CYRX | Jul 29, 2024 | 9.07 | +2.95 |
CS Disco | LAW | Jul 29, 2024 | 5.98 | -2.61 |
CSG Systems International | CSGS | Jul 29, 2024 | 46.15 | +0.44 |
CSP | CSPI | Jul 29, 2024 | 15.14 | +0.07 |
CSW Industrials | CSWI | Jul 29, 2024 | 299.74 | -0.38 |
CSX | CSX | Jul 29, 2024 | 34.40 | +0.23 |
CTO Realty Growth | CTO | Jul 29, 2024 | 19.62 | +0.05 |
CTO Realty Growth A Pref | CTO-A | Jul 29, 2024 | 21.28 | +1.33 |
CTS | CTS | Jul 29, 2024 | 51.70 | -1.13 |
CubeSmart | CUBE | Jul 29, 2024 | 48.21 | +1.20 |
Cue Biopharma | CUE | Jul 29, 2024 | 0.65 | -3.46 |
Cullen Frost Bankers B Pref | CFR-B | Jul 29, 2024 | 18.16 | +0.10 |
Cullen/Frost Bankers | CFR | Jul 29, 2024 | 117.98 | -1.47 |
Cullinan Therapeutics | CGEM | Jul 29, 2024 | 19.35 | -4.02 |
Cullman Bancorp | CULL | Jul 29, 2024 | 9.71 | 0.00 |
Culp | CULP | Jul 29, 2024 | 5.09 | +0.99 |
Cumberland Pharmaceuticals | CPIX | Jul 29, 2024 | 1.43 | -2.72 |
Cummins | CMI | Jul 29, 2024 | 291.20 | +0.28 |
Cumulus Media A | CMLS | Jul 29, 2024 | 2.07 | +0.98 |
Curevac N.V. | CVAC | Jul 29, 2024 | 3.67 | -1.34 |
CuriosityStream | CURI | Jul 29, 2024 | 1.10 | -1.79 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.